Global /Canada /Healthcare /Medical Devices /DTR

DiagnosTear Technologies Inc.

DTR

• CSE: DTR • Delayed

0.2900CAD -9.4%

0.2086 USD

As of 6 June 2026, DiagnosTear Technologies Inc. has a market cap of $12.51M USD, ranking #40060 globally and #1535 in Canada. It ranks #3574 in the Healthcare sector, and #759 in the Medical Devices industry.

Global Rank

40060

Country Rank

1535

Sector Rank

3574

Industry Rank

759

Key Stats

Market Cap

$12.51MUSD

17.45M CAD

Company Profile

Country (HQ)

Canada

Sector

Healthcare

Industry

Medical Devices

CEO

Shimon Gross open_in_new

Founded

2023

Website

diagnostear.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-9.4%	-11%	-25%	-40%	-42%	-44%	16%	-59%	-59%

News

Markets

Exchange	Ticker	Price	Quotes
Canadian Securities Exchange (CSE) MIC: XCNQ PRIMARY	DTR DiagnosTear Technologies Inc ISIN: CA25244H1055 Shares Out.: Shares Outstanding: 60.638M¹ Shares Float: 33.766M² TV: TradingView: CSE: DTR SA: Stock Analysis: CSE: DTR YF: Yahoo Finance: DTR.CN GF: Google Finance: CNSX: DTR BA: Barron's: DTR MS: Morningstar: XCNQ: DTR	0.2900 CAD	TV: TradingView: CSE: DTR SA: Stock Analysis: CSE: DTR YF: Yahoo Finance: DTR.CN GF: Google Finance: CNSX: DTR BA: Barron's: DTR MS: Morningstar: XCNQ: DTR
Cboe Canada (NEO) MIC: NEOE	DTR DiagnosTear Technologies Inc ISIN: CA25244H1055 TV: TradingView: NEO: DTR SA: Stock Analysis: NEO: DTR YF: Yahoo Finance: DTR.NE GF: Google Finance: NEO: DTR BA: Barron's: DTR MS: Morningstar: NEOE: DTR	0.4000 CAD	TV: TradingView: NEO: DTR SA: Stock Analysis: NEO: DTR YF: Yahoo Finance: DTR.NE GF: Google Finance: NEO: DTR BA: Barron's: DTR MS: Morningstar: NEOE: DTR

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About DiagnosTear Technologies Inc.

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases. It develops TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform intended for the identification and monitoring of Dry Eye Syndrome (TeaR DES); TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a proprietary microfluidic tear collector that allows non-invasive collection of 1 microliter of tear fluid and dilution in the assay buffer for downstream analytical testing. DiagnosTear Technologies Inc. was formerly known as Oceanview Technologies Inc. and changed its name to DiagnosTear Technologies Inc. The company was incorporated in 2023 and is headquartered in Rehovot, Israel.

Similar Companies

Industry: Medical Devices (Canada)

Name	Market Cap (USD) diff.	PE	Country
Bausch + Lomb Corp. NYSE: BLCO	$5.47B 44K%	-	Canada
Spectral Medical Inc. TSX: EDT	$290.28M 404.92M CAD 2K%	-	Canada
Profound Medical Corp. TSX: PRN	$238.87M 333.22M CAD 2K%	-	Canada
Theralase Technologies Inc. TSXV: TLT	$64.23M 89.6M CAD 413%	-	Canada
Covalon Technologies Ltd. TSXV: COV	$37.42M 52.2M CAD 199%	55.0	Canada
Perimeter Medical Imaging AI, Inc. TSXV: PINK	$31.69M 44.2M CAD 153%	-	Canada

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 1M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 1M%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 1M%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 1M%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 964K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 814K%	22.2	Ireland

chevron_leftBack